Min Li to Biomarkers, Tumor
This is a "connection" page, showing publications Min Li has written about Biomarkers, Tumor.
Connection Strength
1.770
-
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy. Cancer Res Commun. 2025 Aug 01; 5(8):1288-1297.
Score: 0.773
-
Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Lett. 2015 Jul 10; 363(1):1-6.
Score: 0.378
-
Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors. JAMA Netw Open. 2021 05 03; 4(5):e217728.
Score: 0.144
-
Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188367.
Score: 0.134
-
Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients. Cancer Invest. 2017 Oct 21; 35(9):573-585.
Score: 0.112
-
Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling. Cancer Lett. 2015 Apr 10; 359(2):314-24.
Score: 0.093
-
MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer Res. 2021 10 01; 81(19):4964-4980.
Score: 0.037
-
Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020 08 25; 19(1):130.
Score: 0.034
-
lncRNA-PLACT1 sustains activation of NF-?B pathway through a positive feedback loop with I?Ba/E2F1 axis in pancreatic cancer. Mol Cancer. 2020 02 21; 19(1):35.
Score: 0.033
-
Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of BIRC3/YAP1 as Double Minutes Plus Trisomy 2: A Case Report. Fetal Pediatr Pathol. 2020 Feb; 39(1):51-61.
Score: 0.032